期刊文献+

SIRT1在乳腺癌中的作用 被引量:3

Roles of SIRT1 in breast cancer
下载PDF
导出
摘要 沉默信息调节因子1(sirtuin Type 1,SIRT1)是酵母Sir2的哺乳动物同源体,是一种NAD+依赖的Ⅲ类组蛋白去乙酰化酶,能使组蛋白和非组蛋白去乙酰化,参与细胞多种生理、病理过程,如基因沉默、细胞衰老、寿命延长、抗氧化应激、能量代谢调节、DNA损伤修复、肿瘤发生等。其中,SIRTl在乳腺癌的发生中涉及的上下游信号分子众多,信号通路繁杂而交叉。有研究显示SIRTl起着抑制乳腺癌发生的作用;而有的研究结果正相反,SIRTl起着促进乳腺癌发生的作用。 Sirtuin Type 1(IRT1) is a mammalian homolog of yeast Sir2.It is a nicotinamide adenine dinucleotide(NAD+)-dependent classⅢ histone deacetylase which removes acetyl groups from histones and many non-histone proteins.Therefore it is involved in various physiological and pathological processes in cells such as gene silencing,cell aging,life extension,stress response,energy metabolism,DNA damage repairing,and tumorigenesis.In recent years,many studies have shown that SIRT1 is involved in the occurrence and development of breast cancer.SIRT1 interacts with many upstream and downstream signaling molecules,participating in many complex signaling pathways and cross-pathways.Some studies have shown that SIRTl plays a role in inhibiting breast cancer;on the contrary,the others have shown that SIRTl plays a role in promoting breast cancer.
出处 《国际病理科学与临床杂志》 CAS 2012年第4期352-355,共4页 Journal of International Pathology and Clinical Medicine
关键词 沉默信息调节因子1 乳腺癌 信号通路 SIRT1; breast neoplasm; signaling pathway
  • 相关文献

参考文献27

  • 1Guarente L.Sir2 links chromatin silencing,metabolism, and aging[J]. Genes Dev,2000,14(9):1021-1026.
  • 2Blander G, Guarente L. The Sir2 family of protein deacetylasesEJ. Ann gev Biochem,2004,73:417-435.
  • 3Zhan K, Chai X, Cleemts A, et al. Structure and autoregulation of the yeast Hst2 homolog of Sir2[J].lqat Struct Biol,2003,10(10):864-871.
  • 4Imai S. The NAD + world:a new systemic regulatory network for metabolism and aging-SIRTl,systemic NAD+ biosynthesis,and their importance[J]. Cell Biochem Biophys,2009,S3(2):65-74.
  • 5Grubisha O, Smith BC, Denu JM.Small molecule regulation of Sir2 protein deacetylases[J]. FEBS J,2005,272(18):4607- 4616.
  • 6王丽辉,金炜元,陈勇,王君晖.Sir2基因家族的功能和作用机制[J].细胞生物学杂志,2006,28(6):822-826. 被引量:7
  • 7Kim EJ, Um SJ. SIRTI: roles in aging and cancer[J]. BMB Reports,2008,41(11): 751-756.
  • 8Cohen HY Miller C, Bitterman ICD, et al.Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase[J]. Science,2004,30S (5682) :390-392.
  • 9Deng CX. SIRT1, is it a tumor promoter or tumor suppressor?[J]. Biol Sci,2009,$(2): 147-152.
  • 10Wang RH, Sengupti K, Li C, et al. Impaired DNA damage response, genome instabilityp and tumorigenesis in SIRT1 mutant mice[J]. Cancer Ce11,2008,14(4):312-323.

二级参考文献81

  • 1刘艾林,龙娟,王楠,杜冠华.抗肿瘤药物新靶点:组蛋白去乙酰酶的研究进展[J].药学学报,2005,40(7):585-590. 被引量:8
  • 2Saydab SH, Loria CM, Eberhardt MS, et al. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol,2003,157:1092-1100.
  • 3Cha EJ,Noh SJ,Kwon KS,et al.Expression of DBC1and SIRT1Is Associated with poor prognosis of gastric carcinoma.Clin Cancer Res,2009,15:4453-4459.
  • 4Bordone L, Guarente L. Calorie restriction,SIRT1 and metabolism:understanding longevity.Nat Rev Mol Cell Biol,2005,6:298-305.
  • 5Saunders LR,Verdin E.Sirtuins:critical regulators at the crossroads between cancer and aging.Oncogene,2007,26:5489-5504.
  • 6HidaY,KuboY, MuraoK, et al. Strong expression of a longevityrelated protein,SIRT1,in Bowen's disease.Arch Dermatol Res,2007,299:103-106.
  • 7Derek M,Huffman L,William E,et al.SIRT1 is significantly elevated in mouse and human prostate cancer.Cancer Res,2007,67:6612-6618.
  • 8LeeH,KimKR,NohSJ,etal.Expression of DBC1 and SIRTl is associated with poor prognosis for breast carcinoma. Hum Pathol,2011,42:204-213.
  • 9Firestein R, Blander G, Michan S, et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS ONE,2008,3:e2020.
  • 10Lee JH, Song MY, Song EK. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway.Diabetes,2009,58:344-351.

共引文献11

同被引文献31

  • 1乔爱君,左瑾,刘晓军,邵迪,朱鏐娈,崔安芳,孔星星,方福德,常永生.Sirt1基因的研究进展[J].中国医学科学院学报,2009,31(6):782-785. 被引量:5
  • 2王刚平,张红,梁云爱,张作峰,袁宗怀,郭小艳.β-tubulin-Ⅲ、E-cadherin和α-catenin在乳腺癌及癌前病变中的表达及诊断意义[J].中华诊断学电子杂志,2013,1(1). 被引量:8
  • 3郑英娟,汤建华,张志林,张志华,张秀珑,冯平.肺癌中SPARC和TGFβ1的表达及意义[J].肿瘤防治研究,2014,41(6):593-597. 被引量:5
  • 4Brekken RA, Sage EH. SPARC, a matricellular pro-tein : at the crossroads of cell-matrix communica-tion [J]. Matrix Bi- ol, 2001,19(18) :816-827.
  • 5Mok SC, Chan WY, Wong KK, et al. SPARC, an extracel- lular matrix protein with tumor-suppressing activity in human ovarian epithelial cells [J]. Oncogene,2012,12 : 1895-1901.
  • 6Thomas R,True LD, Bassuk JA, et al. Different expression of osteonectin/SPARC during human prostate cancer pro- gression [J]. Clin Cancer Res, 2000,6 : 1140-1149.
  • 7Puolakkainen PA,Brekken RA,Muneer S,et al. Enhanecd growth of pancreatic tumors in SPARC-nullmice is associ- ated with decreased deposition of extracellul armatrix and reduced tumor cell apoptosis [J]. MolCancer Res,2004, 2(4) :215-224.
  • 8Rotllant J,Liu D,Yan YL, et al. Sparc (Osteonectin) func- tions in morphogenesis of the pharyngeal skeleton and inner ear [J]. Matrix Bio1,2008,27:561-572.
  • 9Marcia CH. Mamma lian sintuins emerging roles in physi- ology,aging and calorie restriction [J]. Gen Dev, 2008,20 (21) :2913-2921.
  • 10Wang H,Liu H,Chen K,et al. SIRT1 promotes tumori- genesis of hepatocellular carcinoma through PI3K/PTEN/ AKT signaling [J]. On-col Rep, 2012,28 : 311-318.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部